Trial in progress

SYS6010 plus immunotherapy as first treatment

SYS6010 combo · CSPC · 737 people planned · Registered completion December 2029

Not yet openRegistered completion December 2029

What is being tested

SYS6010 with the PD-1 drug enlonstobart, with or without 5-FU or capecitabine, against standard first treatment.

Why it matters

Tests whether an antibody-drug conjugate can replace platinum chemotherapy up front.

ClinicalTrials.gov record ↗ ← Back to the outlook

Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.